Crouch or flexed-knee gait is one of the most common pathological gait patterns in cerebral palsy (CP). Differences exist in definitions used; the degree of knee flexion, inclusion of hip or ankle position, and timing in the gait cycle. This ambiguity may be responsible for variations in prevalence rates and difficulty comparing data across studies. What are the kinematic parameters used to define crouch or flexed-knee gait in CP gait? A secondary aim was to examine the quality of data reporting, focusing on the sample characteristics, inclusion/exclusion criteria and the choice of limb included for analysis. Articles included in this review reported on a specified cohort of adults or children with crouch or flexed-knee gait assessed with 3-dimensional gait analysis. A customised data extraction and quality assessment table was designed specific to the research question. The majority (75 %) of included studies used the term crouch gait. Where the pattern was defined, 80 % of crouch papers and 94 % of fficult to make compare data amongst study cohorts. Future research should provide detailed definitions including the threshold value of knee flexion, how it was derived, the timing in the gait cycle and the limb(s) included in analysis. Understanding the impacts of increased adiposity on postural control and cognitive deficits in adults is critical for health practitioners in recommending or prescribing effective weight loss regimens. Despite prior work in this area, the knowledge of increased adiposity impacts on postural control and cognitive deficits in older adults (OAs) is still limited. The purposes of the current study were (a) to assess the relationship between postural measures and adiposity measures by using regression model analyses and, (b) to examine the impacts of increased adiposity and age on cognitive performance. A total of thirty (30) individuals aged 60+ years participated in the study. Participants were classified into three groups based upon their BMI scores at the onset of the study. The normal weight (NW) (BMI 18.5-24.9 kg/m ), the overweight (OW) (BMI 25-29.9 kg/m ), and the obese (OB) groups (BMI 30-40 kg/m ) each had five females and five males. Participants were required to perform two test sessions (1) anthropometry assessment and body composition scanning; and (2) evaluation of plantar tactile function, postural control, and cognitive function. Overall, our findings indicate that increased adiposity in OAs is associated with declines in both cognitive function and postural control. Our data also indicate that measures such as BMI and abdominal fat mass amounts/ratios offer the best insight to the impact of adiposity on cognitive function and postural control measures. However, further work is still needed to clarify the mechanistic links between adiposity and cognitive-postural deficits. Our data also indicate that measures such as BMI and abdominal fat mass amounts/ratios offer the best insight to the impact of adiposity on cognitive function and postural control measures. However, further work is still needed to clarify the mechanistic links between adiposity and cognitive-postural deficits. Balance responses to perturbations often involve the arms in an attempt to either restore balance or protect against impact. Although a majority of research has been dedicated to understanding age-related changes in lower limb balance responses, there is a growing body of evidence supporting age-related changes in arm responses. This systematic review aimed to summarize differences in arm responses between older and younger adults under conditions requiring counterbalancing, reaching to grasping, and protection against impact. Following a systematic review and critical appraisal of the literature, data regarding the arm response in studies comparing young and older adults was extracted. The resulting articles were also assessed for quality to determine risk of bias. Fifteen high quality studies were identified. The majority of these studies reported delayed onsets in muscle activation, differences in arm movement strategies, delayed movement timing, increased impact forces, and greater grasp errors in ots. In contrast to wearable tools (like in-shoe) sensors, lab-based gait assessment (using pressure-sensitive mats or cameras) only acquire data over short distances in non-ecological environments. To examine the concurrent validity of a wearable ZeroWire® footswitch system (Aurion Srl, Milan, Italy) vs. the GAITRite® walkway (CIR systems Inc., NJ, USA) for recording temporal gait parameters. We included 40 healthy participants in a prospective, single-center study. Temporal gait parameters were recorded simultaneously with the ZeroWire® and GAITRite® systems while each participant walked at three different speeds (slow (60steps/min), comfortable and maximum). To measure the validity, we calculated the interclass correlation coefficient (ICC) and the coefficient of variation (CV) for each parameter (gait cadence, stride time, step time, stance time, and single-support and double-support times). We also performed a graphical analysis using the Bland and Altman method. The footswitch system showed moderate- times in healthy participants). It is likely to be well suited to the assessment of gait parameters under ecological conditions and in dual-task gait paradigms.Mycobacterium tuberculosis (Mtb) ATP synthase is an important target for treating drug-resistant infections and sterilizing the bacteria, spurring intensive efforts to develop new TB therapeutics based on this target. In this work, four novel series including furan-2(5H)-ketone (3, 4), maleimide (5) and squaramide (6) derivatives were designed, respectively, through the strategy of scaffold morphing and hydrogen-bond introduction, using the selective Mtb ATP synthase inhibitor compound 2 as the lead compound. The result demonstrated that diamino substituted cyclobut-3-ene-1,2-dione compounds 6ab and 6ah displayed good to excellent in vitro anti-TB activities (MIC 0.452-0.963 μg/mL) with low cytotoxicity (IC50 > 64 μg/mL). In addition, not only did compound 6ab show effective activity against clinically isolated resistant strains, it also revealed good druggability profiles including improved metabolic stability, no hERG channel inhibition potential, and acceptable oral bioavailability. https://www.selleckchem.com/products/furimazine.html The preliminary result of docking study and in vitro anti-bedaquiline-resistant strain test compared to compound 2 suggested that Mtb ATP synthase is most likely the target of compound 6ab.